7 results

• COVID-19 Vaccine Side Effects Linked to Serious Heart Problems and Autoimmune Disorder

  June 5, 2025

  Michael Adams

  Federal health officials are recommending updated warning labels on the Pfizer and Moderna COVID-19 vaccines, citing side effects that may increase the risk of serious heart conditions.

• RSV Vaccine Guillain-Barré Syndrome Side Effects To Be Added to Warning Labels for Abrysvo and Arexvy

  January 8, 2025

  Martha Garcia

  The FDA warns that the RSV vaccines Abryso and Arexvy may carry a risk of Guillain-Barré syndrome, and has required Pfizer and GlaxoSmithKline to add new warnings to the drugs' labels.

• Cancer Diagnosis Increases Risk of Guillain-Barré Syndrome: Study

  March 14, 2022

  Martha Garcia

  Some types of cancer appear to increase the risk of a patient developing a rare neurological disorder which can cause paralysis.

• Shingrix Shingles Vaccine Recommended for Immunocompromised Adults: CDC Reports

  January 21, 2022

  Irvin Jackson

  The CDC says it approves of the use of Shingrix in immunocompromised adults, which was contraindicated for the competing shingles live virus vaccine, Zostavax.

• Shingrix Guillain-Barré Syndrome Risk Seen During 42 Days After Shingles Vaccination: Study

  November 12, 2021

  Irvin Jackson

  The Shingrix vaccine appears to be linked to a small, but statistically significant, increased risk og Guillain-Barre Syndrome, according to the findings of a study which led to new label warnings earlier this year.

• Guillain–Barré Syndrome Warning to be Added to Johnson & Johnson COVID-19 Vaccine

  July 13, 2021

  Irvin Jackson

  The FDA has added new label warnings to the Johnson & Johnson COVID-19 vaccine, indicating it may increase the risk of an autoimmune disorder known as Guillain–Barré syndrome.

• Shingrix Vaccine’s Risk of Guillain-Barré Syndrome Results in New FDA Warning

  March 26, 2021

  Irvin Jackson

  The Shingrix vaccine, used to prevent shingles, may increase the risk of Guillain-Barre Syndrome, which can cause muscle weakness and paralysis, the FDA warns.